DuPont completed the acquisition of Spectrum Plastics Group from AEA Investors for $1.75bn.

DuPont, a company with technology-based materials and solution, completed the acquisition of Spectrum Plastics Group, a company in advanced manufacturing of specialty medical devices and components, from AEA Investors, a private equity firm, for $1.75bn. "We have been focused on Spectrum for a long time and our team is extremely excited for this opportunity. Spectrum is a compelling strategic complement to our existing healthcare portfolio, which already includes businesses with best-in-class innovation, deep customer relationships and with strong growth and profitability. With this combination, we'll be able to offer customers additional innovation and manufacturing capabilities with a broader and more integrated solution set," Ed Breen, DuPont Executive Chairman and CEO.